Hitoshi Hotoda

Biologically Active Oligodeoxyribonucleotides. 5. 5‘-End-Substituted d(TGGGAG) Possesses Anti-Human Immunodeficiency Virus Type 1 Activity by Forming a G-Quadruplex Structure

Hitoshi Hotoda, Makoto Koizumi, Rika Koga et al. · Journal of Medicinal Chemistry · 1998 · 91 citations

Life Sciences, Biochemistry, Pharmacology +17

Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellularein vitro and in vivo

Tetsufumi Koga, Takashi Fukuoka, Norio Doi et al. · Journal of Antimicrobial Chemotherapy · 2004 · 86 citations · Full text

Medicine, Infectious Diseases, Medicinal Chemistry +15

Synthesis and antimycobacterial activity of capuramycin analogues. Part 1: substitution of the azepan-2-one moiety of capuramycin

Hitoshi Hotoda, Miyuki Furukawa, Makiko Daigo et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 60 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

Molecular Recognition of Adenophostin, a Very Potent Ca²⁺ Inducer, at the <scp>d</scp>-<i>myo</i>-Inositol 1,4,5-Trisphosphate Receptor

Hitoshi Hotoda, Kazuhiro Murayama, Shuichi Miyamoto et al. · Biochemistry · 1999 · 43 citations

Medicine, Biochemistry, Pharmacology +17

Synthesis and antimycobacterial activity of capuramycin analogues. Part 2: acylated derivatives of capuramycin-related compounds

Hitoshi Hotoda, Makiko Daigo, Miyuki Furukawa et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 42 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11